Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial

Nature Reviews Cardiology

Volumn 15, Issue 2, 2018, Pages 79-80

  Swirski, Filip K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; DNA; ANTIINFLAMMATORY AGENT; AUTACOID; CARDIOVASCULAR AGENT; IL1B PROTEIN, HUMAN; INTERLEUKIN 1BETA;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL RENEWAL; DIABETES MELLITUS; HEMATOPOIESIS; HUMAN; HYPERTENSION; IMMUNOCOMPETENT CELL; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CARDIOLOGY; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; MASS COMMUNICATION; PATHOPHYSIOLOGY; TRENDS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOLOGY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIFFUSION OF INNOVATION; HEMATOPOIESIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA;

EID: 85040826373     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2017.208     Document Type: Review

References (7)

1. Ross, R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419-S420 (1999).
2. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
3. Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842-847 (2017).
4. Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111-121 (2017).
5. Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488-2498 (2014).
6. Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119-1131 (2017).
7. Ridker, P. M. et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet http://dx.doi.org/10.1016/S0140-6736(17)32814-3 (2017).